Donahoo J S, Gardner T J, Zahka K, Kidd B S
Ann Thorac Surg. 1980 Aug;30(2):146-50. doi: 10.1016/s0003-4975(10)61231-3.
Thirty infants with various types of cyanotic congenitl heart disease underwent systemic-pulmonary artery shunts with a microporous polytetrafluoroethylene (PTFE) graft between May, 1976, and July, 1979. Sixteen of them were less than 1 month old, and the average age of the neonates was 5.3 days. There were no operative deaths and 5 hospital deaths, 2 related directly to the shunt. Five patients required early revision of the shunt. Relief from cyanosis was achieved in each patient. Twenty-five patients have been followed up to three and one-half years. There have been 2 late deaths and one late occlusion of the shunt. One patient outgrew the shunt and required secondary shunting procedures. Three of 30 patients have evidenced mild congestive heart failure, which has responded to digitalis. Because of the reliability and excellent late patency of the PTFE prosthesis, we consider it to be superior to a central or Potts shunt for relief from cyanosis in the neonate and infant, and as reliable as a Blalock-Taussig shunt.
1976年5月至1979年7月期间,30例患有各种类型青紫型先天性心脏病的婴儿接受了使用微孔聚四氟乙烯(PTFE)移植物的体肺分流术。其中16例年龄小于1个月,新生儿的平均年龄为5.3天。无手术死亡病例,有5例住院死亡,其中2例直接与分流术相关。5例患者需要早期对分流术进行修正。每名患者的青紫症状均得到缓解。25例患者已随访至三年半。有2例晚期死亡和1例分流管晚期闭塞。1例患者长大后分流管不再适用,需要进行二次分流手术。30例患者中有3例出现轻度充血性心力衰竭,使用洋地黄治疗后病情得到缓解。由于PTFE假体的可靠性和良好的远期通畅性,我们认为它在缓解新生儿和婴儿青紫症状方面优于中央分流术或Potts分流术,并且与Blalock-Taussig分流术一样可靠。